1,928
Participants
Start Date
January 31, 2013
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)
VCIV manufactured with the current manufacturing process (VCIV current)
Fluzone®, licensed trivalent influenza vaccine (TIV)
Rochester Clinical Research Inc., Rochester
PMG Research of Cary, LLC, Cary
Wake Research Associates, LLC, Raleigh
Spartanburg Medical Research, Spartanburg
Clinical Research Atlanta, Stockbridge
Avail Clinical Research, LLC, DeLand
Clinical Research of South Florida, Coral Gables
Miami Research Associates, South Miami
Rapid Medical Research, Inc., Cleveland
Sundance Clinical Research, LLC, St Louis
The Center for Pharmaceutical Research, P.C., Kansas City
Heartland Research Associates, LLC, Wichita
Benchmark Research, Fort Worth
Benchmark Research Austin, Austin
Jean Brown Research, Salt Lake City
East Valley Family Physicians, PLC, Chandler
Center for Clinical Trials, LLC, Paramount
California Research Foundation, San Diego
Anaheim Clinical Trials, Anaheim
Benchmark Research San Francisco, San Francisco
Alachua Government Services, Inc.
INDUSTRY